Finding Elevidys Requires a Different Approach

If your child's neurologist has recommended Elevidys (Delandistrogene Moxeparvovec-rokl) for Duchenne muscular dystrophy (DMD), you probably already know this isn't a typical prescription you can fill at a pharmacy. Elevidys is a one-time gene therapy infusion that costs $3.2 million and can only be administered at specialized treatment centers.

Finding it "in stock" means finding a qualified treatment center that has the capacity, insurance authorization, and specific weight-based kit (like the 21.5-22.4 kg kit) ready for your child. Here's how to navigate that process effectively.

Tip 1: Use Medfinder to Track Availability

Medfinder helps patients and families locate hard-to-find medications and specialty treatments. For gene therapies like Elevidys, Medfinder can connect you with information about treatment center availability and help you understand your options.

Because Elevidys availability changes frequently — especially after the 2025 shipment pause and label changes — having a tool that tracks real-time information can save you weeks of phone calls.

How to Use Medfinder

• Visit medfinder.com and search for Elevidys
• Review available treatment centers and their current status
• Set up alerts so you're notified when availability changes

Tip 2: Connect Directly With Specialized Treatment Centers

Elevidys is administered at a limited number of neuromuscular disease centers across the United States. These are typically academic medical centers or children's hospitals with dedicated DMD programs. Some of the major centers administering Elevidys include those affiliated with:

• Nationwide Children's Hospital (Columbus, OH — where much of the Elevidys clinical research was conducted)
• UCLA Health
• Children's National Hospital (Washington, DC)
• Boston Children's Hospital
• Other MDA Care Centers and PPMD Certified Duchenne Care Centers

Contact these centers directly to ask about their current capacity for Elevidys infusions. Many have patient coordinators who can help you understand the timeline and requirements.

Ask the Right Questions

When contacting treatment centers, ask:

1. Are you currently scheduling Elevidys infusions for new patients?
2. What is the current wait time from referral to infusion?
3. What insurance plans do you work with for gene therapy coverage?
4. Do you have the specific weight-based kit my child needs (21.5-22.4 kg)?
5. What pre-treatment requirements do I need to complete?

Tip 3: Work With SareptAssist for Guided Access

Sarepta Therapeutics offers a dedicated patient support program called SareptAssist. This is one of the most important resources for families seeking Elevidys. SareptAssist can help with:

• Insurance navigation — They help with prior authorization submissions and appeals
• Treatment center identification — They know which centers are actively administering Elevidys
• Financial assistance — For eligible families, they can help with costs associated with treatment
• Logistics coordination — Including travel support and treatment scheduling

Contact SareptAssist at 1-888-727-3782 (1-888-SAREPTA). Having your child's genetic test results and neurologist information ready when you call will help speed up the process.

What If You Still Can't Find Elevidys?

If you've tried these approaches and are still struggling to access Elevidys, consider these additional steps:

Expand Your Geographic Search

Many families travel significant distances — sometimes across the country — for Elevidys treatment. Since it's a one-time infusion, the travel burden is limited compared to ongoing treatments. Ask SareptAssist about travel assistance programs.

Explore Clinical Trials

While Elevidys itself is commercially available (with restrictions), there may be clinical trials for next-generation gene therapies or related treatments for DMD. Check ClinicalTrials.gov and ask your neurologist about any open studies.

Consider Alternative Treatments While You Wait

If accessing Elevidys is taking longer than expected, make sure your child is on the best available treatment in the meantime. This might include corticosteroids like Deflazacort (Emflaza) or exon-skipping therapies if your child's mutation is amenable. Read more in our guide to Elevidys alternatives.

Connect With Patient Advocacy Groups

Organizations like Parent Project Muscular Dystrophy (PPMD) and the Muscular Dystrophy Association (MDA) have dedicated care navigators and can connect you with families who have successfully navigated the Elevidys access process. Their real-world experience can be invaluable.

Understanding the Weight-Based Kit System

Elevidys is supplied in weight-based kits. The 21.5-22.4 kg kit is specifically formulated for patients in that weight range. This means:

• Your child's weight will be verified before the kit is ordered
• The treatment center must have the correct kit size available
• If your child's weight changes significantly before the scheduled infusion, a different kit may be needed

This weight-based system adds a layer of complexity to the supply chain, which is another reason why early coordination with the treatment center is important.

Final Thoughts

Finding Elevidys in 2026 takes patience, persistence, and the right resources. Start with Medfinder and SareptAssist, connect with specialized treatment centers early, and don't hesitate to reach out to patient advocacy organizations for support.

For more information, explore our other articles: why Elevidys is so hard to find, Elevidys side effects, and how to find a doctor who prescribes Elevidys.